Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for elderly myeloma patients: testing powerful drug duos

NCT ID NCT05572229

Recruiting now Disease control Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

Summary

This study is testing the safety and effectiveness of two different drug combinations for older adults newly diagnosed with multiple myeloma, a blood cancer. It is for patients aged 65 and older who are not eligible for a stem cell transplant. The goal is to see if these combinations can deeply reduce the amount of cancer in the body.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aphp - Chu Henri Mondor

    ACTIVE_NOT_RECRUITING

    Paris, France

  • Aphp - Hopital Saint Antoine

    NOT_YET_RECRUITING

    Paris, France

    Contact

  • Aphp - Hopital Saint Louis

    NOT_YET_RECRUITING

    Paris, France

    Contact

  • Aphp Hopital Avicenne

    NOT_YET_RECRUITING

    Bobigny, France

    Contact

  • Centre Hospitalier de La Cote Basque

    RECRUITING

    Bayonne, France

    Contact

  • Centre Hospitalier de Versailles

    RECRUITING

    Le Chesnay, France

    Contact

  • Centre Leon Berard

    NOT_YET_RECRUITING

    Lyon, France

    Contact

  • Ch D'Avignon

    ACTIVE_NOT_RECRUITING

    Avignon, France

  • Ch de Dunkerque

    ACTIVE_NOT_RECRUITING

    Dunkirk, France

  • Chr Metz-Thionville

    RECRUITING

    Metz, France

    Contact

  • Chru Angers

    RECRUITING

    Angers, France

    Contact

  • Chru Bretonneau

    RECRUITING

    Tours, France

    Contact

  • Chru de Nancy, Hopitaux de Brabois

    RECRUITING

    Nancy, France

    Contact

  • Chu Amiens - Hopital Sud

    RECRUITING

    Amiens, France

    Contact

  • Chu Bordeaux

    RECRUITING

    Pessac, France

    Contact

  • Chu Dijon Bourgogne

    RECRUITING

    Dijon, France

    Contact

  • Chu Limoges

    ACTIVE_NOT_RECRUITING

    Limoges, France

  • Chu Montpellier

    RECRUITING

    Montpellier, France

    Contact

  • Chu Pontchaillou

    ACTIVE_NOT_RECRUITING

    Rennes, France

  • Chu de Besancon

    RECRUITING

    Besançon, France

    Contact

  • Chu de Caen

    RECRUITING

    Caen, France

    Contact

  • Chu de Grenoble

    RECRUITING

    La Tronche, France

    Contact

  • Chu de Lille, Hopital Claude Huriez

    RECRUITING

    Lille, France

    Contact

  • Chu de Nantes Site Hotel Dieu

    ACTIVE_NOT_RECRUITING

    Nantes, France

  • Chu de Poitiers

    RECRUITING

    Poitiers, France

    Contact

  • Chu de Reims

    NOT_YET_RECRUITING

    Reims, France

    Contact

  • Hopital E. Muller- Ghrmsa

    NOT_YET_RECRUITING

    Mulhouse, France

    Contact

  • Hopitaux Universitaire de Strasbourg - Hopital Hautepierre

    RECRUITING

    Strasbourg, France

    Contact

  • Oncopole Chu Toulouse

    RECRUITING

    Toulouse, France

    Contact

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA